A. Muacevic
Papers
2
Total Citations
5
H-Index
2
About
A. Muacevic is a leading figure in the field of stereotactic radiosurgery, with a specific focus on the application of CyberKnife technology for treating oncological conditions. His research primarily centers on advancing non-invasive, high-precision radiation techniques to manage both primary tumors and metastatic disease. A major contribution is his pioneering work on single-fraction robotic stereotactic ablative body radiotherapy (SABR) for locally recurrent prostate cancer following radical prostatectomy. His 2020 study, which has garnered 3 citations, demonstrated the therapeutic potential of this approach for patients with biochemical failure, offering a targeted alternative to more invasive salvage therapies. Beyond prostate cancer, Muacevic has been instrumental in establishing CyberKnife as a viable treatment alternative for patients with inoperable metastases, as highlighted in his 2010 work. By demonstrating the efficacy and reduced invasiveness of this "radiation scalpel," his research has expanded therapeutic options for patients who are not candidates for traditional surgery or thermal ablation, solidifying his impact on the evolution of modern, non-invasive oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2